FAK:癌症治疗的潜在目标
Chao Zhang1, Yu Rao2,1
1Changping Laboratory, Beijing 102206, China.
ACS medicinal chemistry letters
|June 18, 2025
概括
焦点粘附激酶 (FAK) 在癌症中至关重要. 新的 PROTAC 技术完全降解了 FAK 蛋白质,为增强癌症治疗提供了一种超越传统抑制剂的有希望的战略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 焦粘附激酶 (FAK) 是一种非受体氨酸激酶,在癌症的进展,转移和复发中发挥着关键作用.
- FAK具有酶和支架功能,与50多种蛋白质相互作用.
- 现有的FAK抑制剂主要向激酶活性,忽视其支架功能.
研究的目的:
- 探索PROTAC技术作为FAK降解的新策略.
- 评估PROTACs在消除FAK的酶和支架功能方面的潜力.
- 研究涉及FAK降解的组合疗法,以提高抗癌效果.
主要方法:
- 开发针对FAK的蛋白质溶解向金马 (PROTACs).
- 评估 PROTAC 在降解完整的 FAK 蛋白质方面的有效性.
- 探索双目标降解和抑制剂-降解剂策略.
主要成果:
- 已经成功开发了几种针对FAK的PROTAC.
- PROTACs显示出有可能降解整个FAK蛋白质,解决其两个功能.
- 有希望的结果表明,通过FAK降解策略,增强了抗癌疗效.
结论:
- 通过诱导其完全降解,PROTAC技术提供了一种针对FAK的新方法.
- 降解FAK,而不仅仅是抑制其激酶活性,可以克服当前治疗方法的局限性.
- 涉及FAK降解的组合疗法在改善癌症治疗结果方面具有显著的前景.
更多相关视频
10:33Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment
Published on: April 25, 2025
395
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
12.4K
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Mitogens and the Cell Cycle
7.0K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Stem Cells and Tumor Maintenance
5.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K
Adaptive Mechanisms in Cancer Cells
6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
